LITAF and pancreatic neoplasm: The methylation levels of LITAF promoter were significantly increased in 25 pancreatic cancer tissues compared with adjacent normal tissues (p < 0.01, Figure 4D); 3 typical pancreas cancer cases (case 18, 22 and 23) with hypermethylation in LITAF promoter are shown in Figure 4C.